BenzingaTue, 12 May 2026 18:27:41 GMTAlkermes Gains Momentum After Sleep Disorder Trial Clears Key HurdlesALKS-2.29%
BenzingaWed, 06 May 2026 17:54:10 GMTAlkermes Analysts Increase Their Forecasts Following Strong Q1 ResultsALKS-2.29%
Zacks Investment ResearchWed, 06 May 2026 17:10:18 GMTAlkermes' Q1 Earnings & Revenues Beat Estimates, Stock RisesALKS-2.29%
Seeking AlphaWed, 06 May 2026 11:30:08 GMTAlkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS CompanyALKS-2.29%
Seeking AlphaTue, 05 May 2026 19:41:25 GMTAlkermes plc (ALKS) Q1 2026 Earnings Call TranscriptALKS-2.29%
Zacks Investment ResearchTue, 05 May 2026 14:36:19 GMTAlkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesALKS-2.29%
Zacks Investment ResearchTue, 05 May 2026 13:26:39 GMTAlkermes (ALKS) Reports Q1 Loss, Beats Revenue EstimatesALKS-2.29%
Zacks Investment ResearchTue, 28 Apr 2026 15:09:52 GMTEarnings Preview: Alkermes (ALKS) Q1 Earnings Expected to DeclineALKS-2.29%
Zacks Investment ResearchTue, 28 Apr 2026 14:56:28 GMTWall Street Analysts Believe Alkermes (ALKS) Could Rally 29.14%: Here's is How to TradeALKS-2.29%
Zacks Investment ResearchFri, 27 Mar 2026 16:32:09 GMTWhy Is Alkermes (ALKS) Down 2.6% Since Last Earnings Report?ALKS-2.29%
Zacks Investment ResearchWed, 11 Mar 2026 10:15:47 GMTNew Strong Sell Stocks for March 11thALKS-2.29%
Zacks Investment ResearchThu, 26 Feb 2026 17:40:29 GMTAlkermes Down Despite Q4 Earnings Beat, Announces Leadership ChangeALKS-2.29%
Zacks Investment ResearchWed, 25 Feb 2026 18:30:37 GMTAlkermes (ALKS) Reports Q4 Earnings: What Key Metrics Have to SayALKS-2.29%
Zacks Investment ResearchWed, 25 Feb 2026 18:15:57 GMTAlkermes (ALKS) Q4 Earnings and Revenues Top EstimatesALKS-2.29%
Seeking AlphaWed, 25 Feb 2026 17:47:49 GMTAlkermes plc (ALKS) Q4 2025 Earnings Call TranscriptALKS-2.29%
Zacks Investment ResearchTue, 24 Feb 2026 15:15:54 GMTWall Street's Insights Into Key Metrics Ahead of Alkermes (ALKS) Q4 EarningsALKS-2.29%
Zacks Investment ResearchWed, 18 Feb 2026 15:42:00 GMTIs Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year?ALKS-2.29%
Zacks Investment ResearchTue, 17 Feb 2026 18:10:23 GMTWill Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report?ALKS-2.29%
